No image available

Michelle Bone

Associate

Michelle is an associate in the Intellectual Property practice in Washington, D.C.

She represents innovator companies in intellectual property litigation and counselling.

Michelle has served clients in matters involving a broad range of technologies, including pharmaceutical sciences, biotechnology, and high tech. Her experience includes working on a range of patent litigation matters, such as Hatch-Waxman litigation, other district court litigation, Federal Circuit appeals, and post-grant proceedings before the United States Patent and Trademark Office. Michelle has experience with all phases of patent litigation, from pre-suit investigation through trial and appeal.

Michelle clerked for the Hon. James Donato in the Northern District of California and for the Hon. Raymond C. Clevenger, III at the Federal Circuit.

Experience

Representative matters

A multinational pharmaceutical corporation in connection with patent litigation.

A pharmaceutical company asserting infringement of two patents related to ophthalmic products.

A multinational technology company in patent litigation concerning smart household products.

A pharmaceutical innovator in patent litigation relating to a treatment for addiction (previous firm experience).

Leadership Positions And Professional Affiliations

  • Giles S. Rich Inn of Court
  • Federal Circuit Bar Association

Qualifications

Admissions

Admitted to the State Bar of Massachusetts, 2019

Admitted to the State Bar of New York, 2021

Admitted to the Bar of Washington, D.C, 2022

U.S. Court of Appeals for the Federal Circuit, 2020

U.S. Court of Appeals for the Eleventh Circuit, 2023

Academic

J.D., University of Pennsylvania Law School, 2019

B.A., Chemistry and History, Cornell University, 2016

Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.